Aperio Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Aperio Group’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,851	Closed	-$13K	–	2870
2019 Q2	$13K	Buy	+1,851	New	+$10K	﹤0.01%	2755

Other funds holding PLXP

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cranbrook Wealth Management Bloomfield Hills, Michigan $534M AUM 18.5% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Aperio Group's PLXP Position: Q3 2019 in Review

Aperio Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2019, closing a stake of 1,851 shares — an estimated $13K sold.

Aperio Group first reported a position in PLXP in Q2 2019 and held it in 1 quarter. The position peaked at $13K in Q2 2019. 16 funds tracked by Wall St. Rank hold PLXP as of Q3 2019.

Aperio Group reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Aperio Group sold 1,851 PLx Pharma Inc. Common Stock shares in Q3 2019, an estimated $13K.
Aperio Group first reported a position in PLx Pharma Inc. Common Stock in Q2 2019 and held it in 1 quarter.
Aperio Group's PLx Pharma Inc. Common Stock position peaked at $13K in Q2 2019.
16 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.